Antares Pharma Inc. (ATRS)

3.14
NASDAQ : Health Technology
Prev Close 3.12
Day Low/High 3.06 / 3.17
52 Wk Low/High 2.53 / 3.96
Avg Volume 1.06M
Exchange NASDAQ
Shares Outstanding 163.06M
Market Cap 508.75M
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of February 2016 Options Trading For Antares Pharma (ATRS)

First Week of February 2016 Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options become available this week, for the February 2016 expiration.

Antares Pharma To Present At The JMP Securities Life Sciences Conference

Antares Pharma To Present At The JMP Securities Life Sciences Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.

Sell These 7 Health Care Supplies Companies Now

Sell These 7 Health Care Supplies Companies Now

An aging population means the outlook is positive for health care equipment and supplies companies, but not every stock in the industry is a buy.

Antares Pharma Announces Additional Update To QuickShot Testosterone Program

Antares Pharma Announces Additional Update To QuickShot Testosterone Program

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a written update from the U.

Antares Pharma To Present At The Jefferies 2015 Global Healthcare Conference

Antares Pharma To Present At The Jefferies 2015 Global Healthcare Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that James E.

Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the closing of its previously announced firm commitment underwritten public offering of 23,000,000 shares of the Company's common stock, which includes 3,000,000 shares...

First Week of June 19th Options Trading For Antares Pharma (ATRS)

First Week of June 19th Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options begin trading this week, for the June 19th expiration.

First Week of November 20th Options Trading For Antares Pharma (ATRS)

First Week of November 20th Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options become available this week, for the November 20th expiration.

Insider Trading Alert - GMAN, ATRS And MMI Traded By Insiders

Insider Trading Alert - GMAN, ATRS And MMI Traded By Insiders

Stocks with insider trader activity include GMAN, ATRS and MMI

Antares Pharma Reports Fourth Quarter And Full Year 2014 Operating And Financial Results

Antares Pharma Reports Fourth Quarter And Full Year 2014 Operating And Financial Results

Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the fourth quarter and full year ended December 31, 2014.

Antares Pharma To Host Fourth Quarter 2014 Operating And Financial Results Conference Call

Antares Pharma To Host Fourth Quarter 2014 Operating And Financial Results Conference Call

Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter 2014 financial results before the market opens on Thursday, March 12, 2015, and host a conference call shortly thereafter at 8:30 a.

Antares Pharma Announces Positive Top-Line Pharmacokinetic Results From The QuickShot® Phase 3 Study In Testosterone Deficient Men

Antares Pharma Announces Positive Top-Line Pharmacokinetic Results From The QuickShot® Phase 3 Study In Testosterone Deficient Men

Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive top-line pharmacokinetic results that showed that the primary endpoint was achieved in the Company's ongoing, multi-center, phase 3 clinical study (QST-13-003)...

Antares Pharma To Present At The Cowen And Company 35Th Annual Healthcare Conference

Antares Pharma To Present At The Cowen And Company 35Th Annual Healthcare Conference

Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Eamonn P.

Antares Pharma To Present At The 2015 RBC Capital Markets' Global Healthcare Conference

Antares Pharma To Present At The 2015 RBC Capital Markets' Global Healthcare Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.

ATRS: Insiders vs. Shorts

ATRS: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 01/15/2015 settlement date, and Antares Pharma Inc. is one of the most shorted stocks of the Russell 3000, based on 8.45 "days to cover" versus the median component at 5.09.

First Week of ATRS March 20th Options Trading

First Week of ATRS March 20th Options Trading

Investors in Antares Pharma Inc. saw new options begin trading this week, for the March 20th expiration.

Antares Pharma Provides Regulatory Update On Sumatriptan Injection USP

Antares Pharma Provides Regulatory Update On Sumatriptan Injection USP

Antares Pharma, Inc. (NASDAQ:ATRS) today announced that the U.

Antares Pharma Announces Update To QuickShot® Testosterone Program

Antares Pharma Announces Update To QuickShot® Testosterone Program

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received written recommendations from the U.

Antares Pharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference

Antares Pharma To Present At The 33rd Annual J.P. Morgan Healthcare Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.

Interesting ATRS Put Options For August 2015

Interesting ATRS Put Options For August 2015

Investors in Antares Pharma Inc. saw new options become available this week, for the August 2015 expiration.

Short Interest In Antares Pharma Decreases By 11%

Short Interest In Antares Pharma Decreases By 11%

The most recent short interest data has been released by the NASDAQ for the 11/28/2014 settlement date, which shows a 1,559,189 share decrease in total short interest for Antares Pharma Inc. , to 12,464,088, a decrease of 11.12% since 11/14/2014.

TheStreet Quant Rating: C (Hold)